Clinical Trial Update: Stem Cell Transplant w/Laronidase for Hurler [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating stem cell transplant with Laronidase for Hurler syndrome (Mucopolysaccharidosis I) has completed enrollment with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hurler Syndrome
• Mucopolysaccharidosis Type

Drugs mentioned

• Laronidase (iduronidase)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Mucopolysaccharidosis I, Hurler Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2019-07-11